CIK 0001817241 · <br>Emerging growth company
Artiva Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARTV
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863614316
- Phone
- (858) 267-4467
- Business address
- 5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Grant or award Chief Medical Officer acquired 50,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Grant or award President and CEO acquired 200,000 shares (grant or award)
- 4 Grant or award SVP, Research and Development acquired 33,350 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 60,000 shares (grant or award)
- 4 Grant or award Chief Tech Operations Officer acquired 60,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 60,000 shares (grant or award)
- 4 Grant or award COO, CLO, Secy, Compliance Off acquired 86,650 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 8 of 12 · 234 filings